Company / Accounts Receivable
Steris Accounts Receivable History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$1.0B
FY2025
5-year range
$609.4M / $1.0B
FY2021-FY2025
Trend
+3.5%
vs FY2024
Sector context
#25 of 143
Health Care
What the data says
Steris's accounts receivable of $1.0B is higher than 83% of companies in the Health Care sector (FY2025). Accounts Receivable has increased for 7 consecutive years, from $528M in FY2018 to $1.0B in FY2025.
Based on SEC 10-K filings.
$1.0B in FY2025 with a 5-year CAGR of +12.2%. Top quartile in the Health Care sector.
Improved from $865M to $1.0B over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +9.3%
- 5-Year CAGR
- +12.2%
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 143This company $1.0B Sector average $1.3B
▼
-21.5% below sector average
Key checks
Key Insights
- Steris's accounts receivable has grown for 7 consecutive years.
- 5-year CAGR of +12.2%, indicating consistent growth.
- In FY2025, accounts receivable increased 3.5% year-over-year.
- Ranks #25 out of 143 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.0B | +3.5% |
| FY2024 | $1.0B | +16.6% |
| FY2023 | $865.0M | +8.3% |
| FY2022 | $799.0M | +31.1% |
| FY2021 | $609.4M | +3.9% |
| FY2020 | $586.5M | +3.8% |
| FY2019 | $564.8M | +7.0% |
| FY2018 | $528.1M | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 13, 2026